Effects of inhibitors of the heat shock protein 90 (HSP90) chaperone activity and inhibitors of the heat shock protein (HSP) expression on sensitivity of HeLa tumor cells to hyperthermia were studied. It was found that nanomolar concentrations of inhibitors of the HSP90 activity (17AAG or radicicol) slowed down chaperone-dependent reactivation of a thermo-labile reporter (luciferase) in heat-stressed HeLa cells and slightly enhanced their death following incubation for 60 min at 43°C. Herein, the inhibitors of HSP90 activity stimulated de novo induction of additional chaperones (HSP70 and HSP27) that significantly increased the intracellular HSP levels. If the cells were treated with 17AAG or radicicol along with an inhibitor of the HSP induction (e.g. quercetin or triptolid, or NZ28), this fully prevented the increase in intracellular chaperone levels resulting from the inhibition of HSP90 activity and subsequent heating. Importantly, in the case of conjunction of all the three treatments (an inhibitor of the HSP90 activity + an inhibitor of the HSP induction + 43°C for 60 min), the reporter reactivation was retarded yet stronger while the cell death was sharply (2-3-fold) enhanced. Such an enhancement of the cytotoxicity appears to occur owing to the "chaperone deficiency" when prior to heat stress both the functional activity of constitutive HSP90 and the expression of additional (inducible) chaperones are blocked in the cells.
Kudryavtsev V.A., Makarova Y.M., Kabakov A.E. (2012) Thermosensitization of tumor cells with inhibitors of chaperone activity and expression. Biomeditsinskaya Khimiya, 58(6), 662-672.
Kudryavtsev V.A. et al. Thermosensitization of tumor cells with inhibitors of chaperone activity and expression // Biomeditsinskaya Khimiya. - 2012. - V. 58. -N 6. - P. 662-672.
Kudryavtsev V.A. et al., "Thermosensitization of tumor cells with inhibitors of chaperone activity and expression." Biomeditsinskaya Khimiya 58.6 (2012): 662-672.
Kudryavtsev, V. A., Makarova, Y. M., Kabakov, A. E. (2012). Thermosensitization of tumor cells with inhibitors of chaperone activity and expression. Biomeditsinskaya Khimiya, 58(6), 662-672.
Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gelermann J., Riess H., Felix R., Schlag P.M. (2002) Lancet Oncol., 3, 487-497. CrossRef Scholar google search
Takahashi I., Emi Y., Hasuda S., Kakeji Y., Naehara Y., Sugimachi K. (2002) Surgery, 131, S78-S84. CrossRef Scholar google search
Westermann A.M., Jones E.L., Schem B.C., van der Steen-Banasik E.M., Koper P., Mella O., Uitterhoeve O.L., de Wit R., van der Velden J., Burger C., van der Wilt C.L., Dahl O., Prosnitz L.R., van der Zee J. (2005) Cancer, 104, 763-770. CrossRef Scholar google search
Kabakov A.E. (2009) in: Anticancer Drugs: Design, Delivery and Pharmacology (Spencer P., Holt W., eds.), Nova Science Publishers, New York, pp. 87-113. Scholar google search
Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., Burrows F.J. (2003) Nature, 425, 407-410. CrossRef Scholar google search
Bagatell R., Paine-Murrieta G.D., Taylor C.W., Pulcini E.J., Akinaga S., Benjamin I.J., Whitesell L. (2000) Clin. Cancer Res., 6, 3312-3318. Scholar google search
McMillan D.R., Xiao X., Shao L., Graves K., Benjamin I.J. (1998) J. Biol. Chem., 273, 7523-7528. CrossRef Scholar google search
Hosokawa N., Hirayoshi K., Kudo H., Takeshi H., Aoike A., Kawai K., Nagata K. (1992) Mol. Cell. Biol., 12, 3490-3498 . CrossRef Scholar google search
Westerheide S.D., Kawahara T.L.A., Orton K., Morimoto R.I. (2007) J. Biol. Chem., 281, 9616-9622. CrossRef Scholar google search
Zaarur N., Gabai V.L., Porco J.A., Calderwood S., Sherman M.Y. (2006) Cancer Res., 66, 1783-1791. CrossRef Scholar google search
Michels A.A., Nguyen V.T., Konings A.W.T., Kampinga H.H., Bensaude O. (1995) Eur. J. Biochem., 234, 382-389. CrossRef Scholar google search
Kampinga H.H., Kanon B., Salomons F.A., Kabakov A.E., Patterson C. (2003) Mol. Cell. Biol., 23, 4948-4958. CrossRef Scholar google search
